https://www.selleckchem.com/pr....oducts/2-hydroxybenz
0±1.5 on a 0-10 numerical rating scale with DRG-S (P0.01). From baseline to with DRG-S, PPT on the most painful location on the low back increased from 28.7±13.6 to 43.4±17.2N/cm (P0.01). MDT on the same location decreased from 8.1±10.4 to 3.4±4.7mN (P=0.07). PPT on the control location and CPM did not change significantly. Our results suggest that DRG-S in CLBP patients reduces deep-tissue hyperalgesia in the low back, while improving mechanoreceptive perception. These changes in both neuropathic and nociceptive co
Aimer
Commentaire
Partagez
